AbbVie Inc. (ABBV) operating KPIs
ABBVNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 3, 2026Score 10/3094% above fair value
$294.89+4.10 (+1.41%)
Close on Oct 30, 2026Market cap $521.11BP/E 83.3Yield 2.26%
AbbVie valuation Inputs — Discount Rate Weighted Average (%) (%)
Form 10-Q / 10-K Fair Value Measurements Note
Latest, FY2025
4.0%
Period ended Dec 31, 2025
Change on a year earlier
-0.8 pts
4.8% in FY2024
History
6 years
Since FY2020
Sources
6
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Valuation Inputs — Discount Rate Weighted Average (%) (%) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4.0% | -0.8 pts | Form 10-Q (filed 2026-08-03) ↗ |
| FY2024 | Dec 31, 2024 | 4.8% | +0.3 pts | Form 10-K (filed 2026-02-20) ↗ |
| FY2023 | Dec 31, 2023 | 4.5% | -0.3 pts | Form 10-K (filed 2025-02-14) ↗ |
| FY2022 | Dec 31, 2022 | 4.8% | +3.1 pts | Form 10-K (filed 2024-02-20) ↗ |
| FY2021 | Dec 31, 2021 | 1.7% | +0.6 pts | Form 10-K (filed 2023-02-17) ↗ |
| FY2020 | Dec 31, 2020 | 1.1% | – | Form 10-K (filed 2022-02-18) ↗ |
Cite this data
StockData. (2026). AbbVie Valuation Inputs — Discount Rate Weighted Average (%) (%), annual FY2020–FY2025 [Data set]. Compiled from AbbVie SEC filings and investor materials. https://stockdatahq.com/stocks/abbv/kpis/cc_disc_wavg
See every metric in the AbbVie KPI table. Data updated Oct 26, 2026.